ZOLEA, Fabiana
ZOLEA, Fabiana
DIPARTIMENTO. FARMACO-BIOLOGICO (attivo dal 01/01/1900 al 30/09/2014)
Central role of estrogen receptor α in adrenocortical tumor cell proliferation.
2011-01-01 Sirianni, Rosa; Zolea, Fabiana; Chimento, Adele; DE LUCA, Arianna; Fallo, Francesco; Pilon, Catia; Arnaldi, Giorgio; Pezzi, Vincenzo.
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation.
2010-01-01 Sirianni, Rosa; Zolea, Fabiana; Chimento, Adele; DE LUCA, Arianna; Fallo, Francesco; Pilon, Catia; Arnaldi, Giorgio; Andò, Sebastiano; Pezzi, Vincenzo.
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
2015-01-01 Chimento, A.; Sirianni, R.; Casaburi, I.; Zolea, F.; Rizza, P.; Avena, P.; Malivindi, R.; de Luca, A.; Campana, C.; Martire, E.; Domanico, F.; Fallo, F.; Carpinelli, G.; Cerquetti, L.; Amendola, D.; Stigliano, A.; Pezzi, V.
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax
2011-01-01 Chimento, A.; Sirianni, R.; Zolea, F.; Bois, C.; Delalande, C.; Ando, S.; Maggiolini, M.; Aquila, S.; Carreau, S.; Pezzi, V.
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells
2009-01-01 Sirianni, R.; Chimento, A.; De Luca, A.; Zolea, F.; Carpino, A.; Rago, V.; Maggiolini, M.; Ando, S.; Pezzi, V.
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system
2012-01-01 Chimento, A.; Sirianni, R.; Zolea, F.; De Luca, A.; Lanzino, M.; Catalano, S.; Ando, S.; Pezzi, V.
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment
2012-01-01 Sirianni, R.; Zolea, F.; Chimento, A.; Ruggiero, C.; Cerquetti, L.; Fallo, F.; Pilon, C.; Arnaldi, G.; Carpinelli, G.; Stigliano, A.; Pezzi, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Central role of estrogen receptor α in adrenocortical tumor cell proliferation. | 1-gen-2011 | Sirianni, Rosa; Zolea, Fabiana; Chimento, Adele; DE LUCA, Arianna; Fallo, Francesco; Pilon, Catia; Arnaldi, Giorgio; Pezzi, Vincenzo. | |
| Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. | 1-gen-2010 | Sirianni, Rosa; Zolea, Fabiana; Chimento, Adele; DE LUCA, Arianna; Fallo, Francesco; Pilon, Catia; Arnaldi, Giorgio; Andò, Sebastiano; Pezzi, Vincenzo. | |
| GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo | 1-gen-2015 | Chimento, A.; Sirianni, R.; Casaburi, I.; Zolea, F.; Rizza, P.; Avena, P.; Malivindi, R.; de Luca, A.; Campana, C.; Martire, E.; Domanico, F.; Fallo, F.; Carpinelli, G.; Cerquetti, L.; Amendola, D.; Stigliano, A.; Pezzi, V. | |
| Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax | 1-gen-2011 | Chimento, A.; Sirianni, R.; Zolea, F.; Bois, C.; Delalande, C.; Ando, S.; Maggiolini, M.; Aquila, S.; Carreau, S.; Pezzi, V. | |
| Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells | 1-gen-2009 | Sirianni, R.; Chimento, A.; De Luca, A.; Zolea, F.; Carpino, A.; Rago, V.; Maggiolini, M.; Ando, S.; Pezzi, V. | |
| Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system | 1-gen-2012 | Chimento, A.; Sirianni, R.; Zolea, F.; De Luca, A.; Lanzino, M.; Catalano, S.; Ando, S.; Pezzi, V. | |
| Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment | 1-gen-2012 | Sirianni, R.; Zolea, F.; Chimento, A.; Ruggiero, C.; Cerquetti, L.; Fallo, F.; Pilon, C.; Arnaldi, G.; Carpinelli, G.; Stigliano, A.; Pezzi, V. |